Acute Myeloid Leukemia (AML)

General Director of Clínica Ruiz, Center of Hematology and Internal Medicine of Puebla; Director of research Division of Laboratorios Ruiz, within Clínica Ruiz; Professor of Hematology at the Autonomous Popular University of the State of Puebla

Hemant S. Murthy M.D., is a Hematology/Oncology physician, with specialty interest in BMT/CAR-T and acute leukemia practice. Dr. Murthy previously served as Assistant Professor of Medicine at the University of Florida College of Medicine in Gainesville, Florida. Prior to joining UF Health, Dr. Murthy was a transplant and cellular immunotherapy fellow at Moffitt Cancer Center.

The focus of Dr. Garcia's research is to develop novel proof-of-concept studies to gain insight on the underlying pathophysiology of acute leukemia and to identify biological predictors of response by partnering with Dana-Farber Cancer Institute laboratory investigators.

Dr. Traer completed a fellowship in hematology/oncology from Oregon Health & Science University. He received his M.D./Ph.D. from the University of Texas Southwestern Medical School and completed a residency in internal medicine at Oregon Health & Science University. In addition to practicing general hematology at OHSU Knight Cancer Institute, Dr. Traer is involved in clinical trials evaluating targeted therapy with kinase inhibitors in leukemia patients. He is performing research with Brian Druker, M.D. to investigate how the bone marrow microenvironment provides sanctuary to leukemia cells by

Dr. Naval Daver is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center. He completed his medical school from Grant Medical College and Sir J group of Hospitals Mumbai, followed by a residency and fellowship in hematology-oncology from Baylor College of Medicine. He is a clinical investigator with a focus on molecular and immune therapies in AML and Myelofibrosis and is principal investigator on >25 ongoing institutional, national and international clinical trials in these diseases.